| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Vice Chairman | CEO | See Remarks +4 more
4 companies
Weiss Michael S is a CEO at TGTX, with reported holdings spanning 4 companies. Recent filings cover 4 purchases and 2 sales.
Our model assigns Weiss Michael S a middling insider score of 63/100, based on 5 past trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +24.7%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2023 | FBIO Fortress Biotech, Inc. | See Remarks | Buy | 147,058 | $1.70 | $249,998.60 | +15.0% | +45.5% | +25.0% | |
| Aug 11, 2023 | TGTX Tg Therapeutics, Inc. | CEO And President | Buy | 100,000 | $10.13 | $1,013,000.00 | +0.8% | +0.1% | +96.6% | |
| Feb 10, 2023 | FBIO Fortress Biotech, Inc. | See Remarks | Buy | 1,197,604 | $0.84 | $999,999.34 | +8.8% | -5.1% | -83.6% | |
| Jan 5, 2022 | TGTX Tg Therapeutics, Inc. | CEO And President | Sell | 68,220 | $18.80 | $1,282,526.81 | -0.6% | -40.2% | -41.6% | |
| Jun 26, 2019 | TGTX Tg Therapeutics, Inc. | CEO And President | Buy | 50,000 | $7.04 | $351,750.00 | +0.4% | - | - |